Federal officials are reducing barriers to medical cannabis access through new regulatory changes. The acting attorney general released a memorandum announcing plans to reclassify cannabis products from their current position in the most restrictive federal category.
This policy shift represents a significant change in the federal government’s approach to medical marijuana regulation. The reclassification would ease current restrictions that have limited research and access to cannabis-based medical treatments.
